Apremilast treatment of plaque psoriasis (PsO) after systemic therapy in Spanish clinical practice: Data from the APPROPRIATE study

• Váldodahkkit: Pablo de laCueva (Dahkki), Susana Armesto (Dahkki), Encarnacion Montesinos (Dahkki), Francisco Javier García (Dahkki), Ana Maria Morales (Dahkki), Raquel Rivera‐Díaz (Dahkki), Mercedes Hospital (Dahkki), Jordi Mollet (Dahkki), Mar Llamas‐Velasco (Dahkki), Jose‐Manuel Carrascosa (Dahkki), Mercedes García (Dahkki), Jimena Vázquez (Dahkki), Lluís Puig (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Wiley, 2023-09-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Abstract Background Despite the proven efficacy and safety of apremilast to treat plaque psoriasis (PsO), data regarding its real‐world use and patient‐perceived benefits are limited. Objectives Describe apremilast use, persistence and tolerability, and its patient‐perceived benefits and effectivene...